Select for export Phase II, Randomized, Double Blind, Placebo Controlled, Parallel Group, Single Center Study of Psilocybin Efficacy in Major Depression Abstract available at the source but not redistributed here. Read at source. Details Copy citation Copy BibTeX ClinicalTrials.gov 2022-04-28 University of Zurich ClinicalTrials.gov CLINICAL TRIAL psilocybin DepressionAnxietyNeuroplasticity Clinical Trial More
Select for export Adverse experiences resulting in emergency medical treatment seeking following the use of magic mushrooms. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1177/02698811221084063 PubMed 35388724 Copy citation Copy BibTeX Journal of Psychopharmacology 2022-04-06 Kopra EI, Ferris JA, Winstock AR, Young AH, Rucker JJ. Europe PMC Published psilocybin AnxietySpiritualityObservational Study Observational Study More
Select for export Demystifying Psychedelic Treatments in Psychiatry: Is Ego Dissolution the Solution? Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1176/appi.pn.2022.04.4.35 Copy citation Copy BibTeX Psychiatric News 2022-03-23 Michael Avissar, Adrian Jacques H. Ambrose OpenAlex Published psilocybin DepressionAnxietyPTSD Clinical Trial More
Select for export Phenomenological assessment of psychedelics induced experiences: Translation and validation of the German Challenging Experience Questionnaire (CEQ) and Ego-Dissolution Inventory (EDI). Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1371/journal.pone.0264927 PubMed 35294453 Copy citation Copy BibTeX PLoS ONE 2022-03-15 Dworatzyk K, Jansen T, Schmidt TT. Europe PMC Published psilocybin AnxietyConsciousnessMystical Experience Observational Study More
Select for export Virtual Reality as a Moderator of Psychedelic-Assisted Psychotherapy. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.3389/fpsyg.2022.813746 PubMed 35310225 Copy citation Copy BibTeX Unknown journal 2022-03-03 Sekula AD, Downey L, Puspanathan P. Europe PMC Published psilocybin DepressionAnxietyPTSD Other More
Select for export Persisting decreases in state and trait anxiety post-psilocybin: A naturalistic, observational study among retreat attendees Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1101/2022.03.02.22271743 Copy citation Copy BibTeX medRxiv 2022-03-01 Kiraga M, Kuypers KPC, Uthaug MV, Ramaekers J, Mason NL. medRxiv PREPRINT (not peer reviewed) psilocybinpsilocin AnxietyMechanism of ActionPersonality Change Observational Study More
Select for export Effects of the 5-HT2A receptor antagonist volinanserin on head-twitch response and intracranial self-stimulation depression induced by different structural classes of psychedelics in rodents. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1007/s00213-022-06092-x PubMed 35233648 Copy citation Copy BibTeX Unknown journal 2022-03-01 Jaster AM, Elder H, Marsh SA, de la Fuente Revenga M, Negus SS, González-Maeso J. Europe PMC Published psilocybin DepressionAddictionPharmacology Animal Study More
Select for export The Acceptance/Avoidance-Promoting Experiences Questionnaire (APEQ): A theory-based approach to psychedelic drugs' effects on psychological flexibility. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1177/02698811211073758 PubMed 35253518 Copy citation Copy BibTeX Journal of Psychopharmacology 2022-02-28 Wolff M, Mertens LJ, Walter M, Enge S, Evens R. Europe PMC Published psilocybin Mechanism of ActionPsychological FlexibilityObservational Study Observational Study More
Select for export Direct comparison of the acute effects of lysergic acid diethylamide and psilocybin in a double-blind placebo-controlled study in healthy subjects. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1038/s41386-022-01297-2 PubMed 35217796 Copy citation Copy BibTeX Neuropsychopharmacology 2022-02-24 Holze F, Ley L, Müller F, Becker AM, Straumann I, Vizeli P Europe PMC Published psilocybin AnxietyPharmacologyHealthy Volunteers Clinical Trial More
Select for export The Therapeutic Potential of Psychedelic-assisted Therapies for Symptom Control in Patients Diagnosed With Serious Illness: A Systematic Review. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1016/j.jpainsymman.2022.01.024 PubMed 35157985 Copy citation Copy BibTeX Unknown journal 2022-02-10 Maia LO, Beaussant Y, Garcia ACM. Europe PMC Published psilocybin AnxietySpiritualityRandomized Controlled Trial Randomized Controlled Trial More
Select for export Psychedelic-assisted psychotherapy for the treatment of major depression: a synthesis of phenomenological explanations. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1007/s11019-022-10070-7 PubMed 35064398 Copy citation Copy BibTeX Unknown journal 2022-01-21 Miceli McMillan R, Jordens C. Europe PMC Published psilocybin Depression Other More
Select for export SPECIAL ISSUE: Do Biofeedback, Neurofeedback, and Neuromeditation Have a Role in Psychedelic-Assisted Therapies? Abstract available at the source but not redistributed here. Read at source. Details DOI 10.5298/1081-5937-50.03.03 Copy citation Copy BibTeX Biofeedback 2021-12-31 Jeff Tarrant OpenAlex Published psilocybin DepressionAnxietyPTSD Clinical Trial More
Select for export An Interpretative Phenomenological Analysis of the use of psilocybin by veterans with symptoms of trauma Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1177/20503245221124117 Copy citation Copy BibTeX Drug Science Policy and Law 2021-12-31 F. N. Smith, Joanna C. Neill, Verity Wainwright OpenAlex Published psilocybin Clinical TrialVeteransSafety Clinical Trial More
Select for export Psychedelic use predicts objective knowledge about climate change via increases in nature relatedness Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1177/20503245221129803 Copy citation Copy BibTeX Drug Science Policy and Law 2021-12-31 Christina Sagioglou, Matthias Forstmann OpenAlex Published psilocybin AddictionEmotional ProcessingObservational Study Observational Study More
Select for export Psychedelic medicines for mood disorders: current evidence and clinical considerations. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1097/yco.0000000000000759 PubMed 34855694 Copy citation Copy BibTeX PubMed 2021-12-31 Sarris J, Pinzon Rubiano D, Day K, Galvão-Coelho NL, Perkins D. Europe PMC Published psilocybin DepressionPTSDNeuroplasticity Clinical Trial More
Select for export Psilocybin for Trauma-Related Disorders. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1007/7854_2022_366 PubMed 35711024 Copy citation Copy BibTeX Unknown journal 2021-12-31 Khan AJ, Bradley E, O'Donovan A, Woolley J. Europe PMC Published psilocybin DepressionAnxietyPTSD Other More
Select for export Serotonergic psychedelics for depression: What do we know about neurobiological mechanisms of action? Abstract available at the source but not redistributed here. Read at source. Details DOI 10.3389/fpsyt.2022.1076459 PubMed 36844032 Copy citation Copy BibTeX Frontiers in psychiatry 2021-12-31 Husain MI, Ledwos N, Fellows E, Baer J, Rosenblat JD, Blumberger DM PubMed Published psilocybin DepressionBrain ImagingMechanism of Action Review Article More
Select for export Critique of the Royal Australian and New Zealand College of Psychiatrists Psychedelic Therapy Clinical Memorandum, Dated May 2020 Abstract available at the source but not redistributed here. Read at source. Details DOI 10.32996/jmhs.2021.2.2.18 Copy citation Copy BibTeX Journal of Medical and Health Studies 2021-12-30 Victor Chiruta, Paulina K Zemla, Pixie Miller, Nicola Santarossa, John A Hannan OpenAlex Published psilocybin SafetyToxicity Other More
Select for export Psilocybin microdosing does not affect emotion-related symptoms and processing: A preregistered field and lab-based study. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1177/02698811211050556 PubMed 34915762 Copy citation Copy BibTeX Journal of Psychopharmacology 2021-12-16 Marschall J, Fejer G, Lempe P, Prochazkova L, Kuchar M, Hajkova K Europe PMC Published psilocybin DepressionAnxietyMechanism of Action Observational Study More
Select for export Double-blind Placebo-controlled Naturalistic Study of Microdosing With Psilocybin: Effects on Brain Activity, Behavior, Cognition, Creativity, and Mental Health Abstract available at the source but not redistributed here. Read at source. Details Copy citation Copy BibTeX ClinicalTrials.gov 2021-12-15 National Council of Scientific and Technical Research, Argentina ClinicalTrials.gov CLINICAL TRIAL psilocybin Brain ImagingMechanism of ActionMicrodosing Other More
